CHARLI: A Phase Ib/II Trial of Ipilimumab-Nivolumab-denosumab or Nivolumab-Denosumab in Patients with Unresectable Stage III and IV Melanoma.
JOURNAL OF CLINICAL ONCOLOGY(2023)
关键词
Melanoma
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CLINICAL ONCOLOGY(2023)